By Amy Bell
The COVID-19 pandemic has highlighted the importance of rapid health communications, especially as protocols change quickly as new information unfolds. During the pandemic, this has proved especially challenging for public health in keeping non-English speakers up to date with the latest information.
Dr. Lisa Diamond recently published a paper titled, “Providing Equitable Care to Patients with Limited Dominant Language Proficiency Amid the COVID-19 Pandemic.” Dr. Diamond writes, “We know from years of research that patients with Limited English Proficiency experience disparities in timely receipt of public health messaging, understanding of important health information, and access to insurance and health care.”
As an AmeriCorps VISTA serving at Immunize Colorado in Aurora, Colorado, I wanted to create a project that addressed these language barriers and helped get these communities access to the COVID-19 Vaccine.
Since the first COVID-19 vaccines became available, healthcare professionals, community workers, and politicians alike have been urging anyone eligible for a vaccine to get one. With cases still circulating in the U.S. and new variants threatening to worsen conditions, mass vaccination appears to be the best way out of the pandemic.
There are currently three COVID-19 vaccines Moderna, Pfizer, and Johnson & Johnson (J&J), approved through Emergency Use Authorization (EUA) in the United States. So far, over 2.3 million total vaccines have been administered in the country as of April 27, 2021.The most recently approved vaccine, the Johnson & Johnson (Janssen) vaccine, was approved on February 27th, 2021, for all adults (18+).
Guest Post by Angie Anderson
A year ago, no one could have imagined how different the world would be today. Pandemic life is hard: lock downs, capacity restrictions, masks, school shutdowns and online learning, and the worst part—climbing death counts. With a husband who works in the COVID-19 unit of the ICU, I realize how debilitating and potentially deadly a severe case of COVID-19 can be. I don’t want to get this virus and I don’t want to contribute to community spread either. For all these reasons, my family is anxiously awaiting a safe and effective vaccine, which is why I jumped at the chance to participate in a vaccine trial. Read more
The COVID-19 virus has quickly spread across the globe, causing half a million cases and nearly 40,000 deaths. In the U.S., we’ve seen over 160,000 reported cases as of March 30, and the actual number is likely much higher. Disease is spreading rapidly, and health systems are struggling to keep pace. Across the country, non-essential businesses are being required to shut their doors, schools are closing—some for the remainder of the school year—, and state governors are issuing Stay-At-Home orders requiring that people not leave their homes unless absolutely necessary.
We are living in a new and uncertain reality. But to many, the fear and uncertainty surrounding COVID-19 is familiar. This is not the first time our society has experienced a pandemic like COVID-19; it is not the first time that people have been afraid to leave their homes, or that healthcare workers have struggled to keep pace with the number of cases.